• LAST PRICE
    24.3000
  • TODAY'S CHANGE (%)
    0.0000 (0.0000%)
  • Bid / Lots
    19.0900/ 1
  • Ask / Lots
    0.0000/ 0
  • Open / Previous Close
    0.0000 / 24.3000
  • Day Range
    ---
  • 52 Week Range
    Low 7.7400
    High 27.8300
  • Volume
    ---
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Tuesday's close: 24.46
TimeVolumeAVTE
09:32 ET24225.15
09:34 ET40024.73
09:38 ET10024.675
09:39 ET40224.52
09:41 ET89523.71
09:48 ET20024.295
09:50 ET430323.36
09:52 ET10023.43
09:54 ET10023.84
09:56 ET317324.11
09:59 ET96723.805
10:01 ET10023.91
10:03 ET20023.93
10:21 ET10024.67
10:28 ET171024.64
10:30 ET36724.688
10:35 ET10024.38
10:39 ET40024.395
10:51 ET10024.56
10:55 ET10024.12
10:57 ET10024.56
11:02 ET113924.45
11:04 ET89024.45
11:06 ET100124.4
11:08 ET30024.341
11:13 ET59124.04
11:18 ET10023.88
11:22 ET10024
11:24 ET10024.45
11:26 ET10024.62
11:27 ET10024.26
11:29 ET20024.3
11:33 ET10024.22
11:42 ET10024.2
11:45 ET10024.21
11:47 ET10024.57
11:49 ET20024.03
11:51 ET10024.5
11:54 ET10024.12
12:00 ET10024.06
12:12 ET20024.2
12:21 ET10124
12:23 ET10024
12:27 ET10024
12:30 ET10124
12:34 ET20024.13
12:38 ET10024.03
12:43 ET10024.13
12:56 ET10024.01
12:59 ET10024.07
01:06 ET10024
01:08 ET10024.01
01:14 ET10023.98
01:19 ET20024.1
01:24 ET10024
01:28 ET100023.92
01:30 ET10023.995
01:32 ET20024.04
01:46 ET10024
01:51 ET10023.99
01:55 ET70024.21
01:57 ET10023.99
02:00 ET20023.97
02:04 ET10024.09
02:08 ET60024.065
02:13 ET25024
02:18 ET10024.19
02:20 ET10023.98
02:22 ET40024.09
02:24 ET62924.055
02:26 ET40323.95
02:27 ET20023.9
02:29 ET10023.92
02:42 ET84123.89
02:44 ET20023.82
02:47 ET10024.165
02:49 ET20024.2
03:00 ET20024.2
03:07 ET10024.115
03:09 ET10024.115
03:12 ET10024.06
03:14 ET112523.985
03:20 ET50023.9
03:23 ET40023.91
03:27 ET10023.97
03:34 ET20024.0204
03:36 ET53723.9
03:39 ET20024.16
03:41 ET42723.93
03:43 ET20024.18
03:48 ET20024.24
03:52 ET200024.23
03:54 ET10024.44
03:56 ET30024.37
03:57 ET80024.45
03:59 ET90024.3
Data delayed at least 15 minutes.
0 New Today
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesAVTE
Aerovate Therapeutics Inc
593.2M
-18.4x
---
United StatesIMVT
Immunovant Inc
636.5M
-3.7x
---
United StatesGHRS
GH Research PLC
641.4M
-30.4x
---
United StatesKZR
Kezar Life Sciences Inc
606.6M
-9.6x
---
United StatesOCGN
Ocugen Inc
612.9M
-9.3x
---
United StatesPHVS
Pharvaris NV
563.6M
-9.3x
---
As of 2022-08-11

Company Information

Aerovate Therapeutics Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing drugs that improve the lives of patients with rare cardiopulmonary disease. The Company's lead program is a drug that addresses the core disease processes of pulmonary arterial hypertension (PAH). AV-101 is an inhaled dry powder formulation of imatinib that conveniently delivers the medicine directly to the diseased lung tissues while reducing systemic adverse effects. AV-101's anti-proliferative mechanism is distinguished from vasodilatory therapies and is poised to make a meaningful difference in the lives of PAH patients. The Company has completed a Phase I trial in the United States of AV-101 in 82 healthy adults. In its Phase I trial, there were no adverse events associated with AV-101. It anticipates initiating a double-blinded, placebo-controlled, randomized Phase II b/III trial of AV-101. It has conducted Phase III trial.

Contact Information

Headquarters
200 Berkeley Street, Floor 18BOSTON, MA, United States 02116
Phone
617-443-2400
Fax
302-655-5049

Executives

Independent Chairman of the Board
Mark Iwicki
President, Chief Operating Officer, Secretary
Benjamin Dake
Chief Executive Officer, Director
Timothy Noyes
Chief Financial Officer, Treasurer
George Eldridge
Senior Vice President - CMC
Marinus Verjiws

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$593.2M
Revenue (TTM)
$0.00
Shares Outstanding
24.4M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
---
EPS
$-1.32
Book Value
$7.06
P/E Ratio
-18.4x
Price/Sales (TTM)
---
Price/Cash Flow (TTM)
---
Operating Margin
---
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.